The Japanese development agency is stepping beyond traditional grants, joining VCs and corporate giants to finance the expansion of a Ghanaian "phygital" healthcare provider.
Simon Hazell returns to the CEO seat at Bioshroom, betting on high-margin wellness over commodity protein after energy crises and strategic missteps shuttered his previous agritech venture.
iProcure, once a darling of the agritech scene with over $17m in total funding — including a $10.2m Series B in 2022 — collapsed into administration in May 2024.
